RxDoctor Payments Data

Tristan Harrison, MD

Family Medicine · Winter Haven, FLNPI 1891704581

Payments from drug & device makers

$10,608in general payments, 2019–2025

Across 601 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Pfizer$848
  • Novo Nordisk$810
  • Boehringer Ingelheim$751
  • Amgen$692
  • GSK$644
  • plus $5K from 36 others

What the payments were for

  • Food & beverage$10,602100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,608 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$408,101
Medicare patients
507
Services billed
8,632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban178$210,260
JardianceEmpagliflozin91$145,151
TrulicityDulaglutide95$105,944
XareltoRivaroxaban91$105,016
OzempicSemaglutide63$83,433
Trelegy ElliptaFluticasone/Umeclidin/Vilanter77$74,165
MyrbetriqMirabegron52$55,565
FarxigaDapagliflozin Propanediol54$52,620
JanuviaSitagliptin Phosphate21$34,484
EntrestoSacubitril/Valsartan25$30,994
RybelsusSemaglutide26$28,710
LinzessLinaclotide30$23,993
Spiriva RespimatTiotropium Bromide34$19,623
Tresiba Flextouch U-100Insulin Degludec42$17,913
MounjaroTirzepatide11$14,420

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$848$210,260178 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$751$172,813141 claims
Lilly USA, LLCTrulicity, Mounjaro$529$120,364106 claims
Novo NordiskOzempic, Rybelsus$810$112,14389 claims
Johnson & JohnsonXarelto$114$105,01691 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$644$89,875111 claims
AstraZenecaFarxiga, Symbicort$1,602$62,67082 claims
Astellas Pharma US IncMyrbetriq$148$55,56552 claims
MerckJanuvia, Janumet Xr$360$43,58533 claims
NovartisEntresto$335$30,99425 claims
AbbVieLinzess, Synthroid$593$27,83090 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Winter Haven

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →